Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67. Zhao F, Zhao J, Wei X, Shi Y, et al. Prostate 2024 Apr 17. doi: 10.1002/pros.24710.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao F, Zhao J, Wei X, Shi Y, et al. Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67. Prostate 2024 Apr 17. doi: 10.1002/pros.24710.
PMID: 38629249